These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37257726)

  • 1. Implementing a randomised controlled trial through community pharmacies to support people living with severe and persistent mental illness: Lessons learnt during the COVID-19 pandemic.
    O'Reilly CL; McMillan SS; El-Den S; Collins JC; Hu J; Ng R; Stewart V; Pham L; Webb F; Roennfeldt H; Segrott R; Loller H; Wheeler AJ
    Contemp Clin Trials; 2023 Aug; 131():107246. PubMed ID: 37257726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bridging the gap between physical and mental illness in community pharmacy (
    Wheeler AJ; O'Reilly CL; El-Den S; Byrnes J; Ware RS; McMillan SS
    BMJ Open; 2020 Jul; 10(7):e039983. PubMed ID: 32709657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the implementation of a novel community pharmacist-led support service for people living with severe and persistent mental illness.
    Ng R; El-Den S; Collins JC; Stewart V; McMillan SS; Hu J; Wheeler AJ; O'Reilly CL
    Res Social Adm Pharm; 2024 Jun; 20(6):113-122. PubMed ID: 38467520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a training program to support the implementation of a community pharmacist-led support service for people living with severe and persistent mental illness.
    Ng R; El-Den S; Collins JC; Hu J; McMillan SS; Wheeler AJ; O'Reilly CL
    J Am Pharm Assoc (2003); 2023; 63(3):807-816.e2. PubMed ID: 36788042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiences of goal planning in Australian community pharmacy settings for people experiencing mental illness: A qualitative study.
    Stewart V; McMillan SS; Hu J; Collins JC; El-Den S; O'Reilly C; Wheeler AJ
    Health Expect; 2023 Dec; 26(6):2205-2215. PubMed ID: 37424358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia.
    Parajuli DR; Khanal S; Wechkunanukul KH; Ghimire S; Poudel A
    Res Social Adm Pharm; 2022 Aug; 18(8):3453-3462. PubMed ID: 34810136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of diabetes screening in community pharmacy - factors influencing successful implementation.
    Siu AHY; Krass I; Mitchell B; McNamara K
    Res Social Adm Pharm; 2021 Sep; 17(9):1606-1613. PubMed ID: 33414090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are SMART goals fit-for-purpose? Goal planning with mental health service-users in Australian community pharmacies.
    Stewart V; McMillan SS; Hu J; Collins JC; El-Den S; O'Reilly CL; Wheeler AJ
    Int J Qual Health Care; 2024 Feb; 36(1):. PubMed ID: 38381655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual health promotion in people with severe mental illness: the RESPECT feasibility RCT.
    Hughes E; Mitchell N; Gascoyne S; Moe-Byrne T; Edmondson A; Coleman E; Millett L; Ali S; Dare C; Hewitt C; Johnson S; Llewellyn C; Mercer C; Nolan F; Walker C; Watson J
    Health Technol Assess; 2019 Dec; 23(65):1-136. PubMed ID: 31854292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An intervention to improve the quality of life in children of parents with serious mental illness: the Young SMILES feasibility RCT.
    Abel KM; Bee P; Gega L; Gellatly J; Kolade A; Hunter D; Callender C; Carter LA; Meacock R; Bower P; Stanley N; Calam R; Wolpert M; Stewart P; Emsley R; Holt K; Linklater H; Douglas S; Stokes-Crossley B; Green J
    Health Technol Assess; 2020 Nov; 24(59):1-136. PubMed ID: 33196410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adapting Peer Researcher Facilitated Strategies to Recruit People Receiving Mental Health Services to a Tobacco Treatment Trial.
    Baker AL; McCarter K; Brophy L; Castle D; Kelly PJ; Cocks N; McKinlay ML; Brasier C; Borland R; Bonevski B; Segan C; Baird DE; Turner A; Williams JM; Forbes E; Hayes L; Attia J; Lambkin D; Barker D; Sweeney R
    Front Psychiatry; 2022; 13():869169. PubMed ID: 35722563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
    Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
    Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative exploration of mental health services provided in community pharmacies.
    Crespo-Gonzalez C; Dineen-Griffin S; Rae J; Hill RA
    PLoS One; 2022; 17(5):e0268259. PubMed ID: 35551556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mental health impact of COVID-19 on pre-registration nursing students in Australia: Findings from a national cross-sectional study.
    Usher Am K; Jackson D; Massey D; Wynaden D; Grant J; West C; McGough S; Hopkins M; Muller A; Mather C; Byfield Z; Smith Z; Ngune I; Wynne R
    J Adv Nurs; 2023 Feb; 79(2):581-592. PubMed ID: 36453452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist-led interventions for people living with severe and persistent mental illness: A systematic review.
    Ng R; El-Den S; Stewart V; Collins JC; Roennfeldt H; McMillan SS; Wheeler AJ; O'Reilly CL
    Aust N Z J Psychiatry; 2022 Sep; 56(9):1080-1103. PubMed ID: 34560826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.